Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ELMO2 (Engulfment and cell motility protein 2) is a cytoplasmic adapter protein involved in signaling pathways that regulate cytoskeletal reorganization, cell migration, and phagocytosis of apoptotic cells. It participates in the activation of Rac1 GTPase via interaction with Dock proteins, influencing cell motility and potentially cancer cell invasion. ELMO2 is not a classical therapeutic target like enzymes or receptors, but may be studied in disease states where cell migration and engulfment are relevant[1].
Modulation of signaling pathways involved in actin cytoskeleton regulation; Interacts with Dock family proteins to modulate Rac1 GTPase signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Engulfment and cell motility protein 2 (ELMO2).